Riordan J, Rommens J, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou J, Drumm M, Iannuzzi M, Collins F, Tsui LC: Identification of the cystic fibrosis gene: cloning and characterisation of complementary DNA. Science. 1989, 245: 1066-1073.
Article
PubMed
CAS
Google Scholar
Dorin JR, Dickinson P, Alton EWFW, Smith N, Geddes DM, Stevenson BJ, Kimber WL, Fleming S, Clarke AR, Hooper ML, Anderson L, Beddington RSP, Porteous DJ: Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature. 1992, 359: 211-215. 10.1038/359211a0.
Article
PubMed
CAS
Google Scholar
Dorin JR, Stevenson BJ, Fleming S, Alton EWFW, Dickinson P, Porteous DJ: Long term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild-type Cftr gene expression. Mamm Genome. 1994, 5: 465-472. 10.1007/BF00369314.
Article
PubMed
CAS
Google Scholar
Chiba-Falek O, Parad RB, Kerem E, Kerem B: Variable levels of normal RNA in different fetal organs carrying a cystic fibrosis transmembrane conductance regulator splicing mutation. Am J Respir Crit Care Med. 1999, 159: 1998-2002.
Article
PubMed
CAS
Google Scholar
Ramalho AS, Beck S, Meyer M, Penque D, Cutting GR, Amaral MD: Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am J Respir Cell Mol Biol. 2002, 27: 619-627.
Article
PubMed
CAS
Google Scholar
Pagani F, Stuani C, Tzetis M, Kanavakis E, Efthymiadou A, Doudounakis S, Casals T, Baralle FE: New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12. Hum Mol Genet. 2003, 12: 1111-1120. 10.1093/hmg/ddg131.
Article
PubMed
CAS
Google Scholar
Teng H, Jorissen M, Van Poppel H, Legius E, Cassiman J-J, Cuppens H: Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells. Hum Mol Genet. 1997, 6: 85-90. 10.1093/hmg/6.1.85.
Article
PubMed
CAS
Google Scholar
Chiba-Falek O, Kerem E, Shoshani T, Aviram M, Augarten A, Bentur L, Tal A, Tullis E, Rahat A, Kerem B: The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-T mutation. Genomics. 1998, 53: 276-283. 10.1006/geno.1998.5517.
Article
PubMed
CAS
Google Scholar
Nissim-Rafinia M, Aviram M, Randell SH, Shushi L, Ozeri E, Chiba-Falek O, Eidelman O, Pollard HB, Yankaskas JR, Kerem B: Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation. EMBO reports. 2004, 5: 1071-1077. 10.1038/sj.embor.7400273.
Article
PubMed
CAS
PubMed Central
Google Scholar
Davidson JD, Dorin JR, McLachlan G, Ranaldi V, Lamp D, Doherty C, Govan J, Porteous DJ: Lung disease in cystic fibrosis mouse exposed to bacterial pathogens. Nat Genet. 1995, 9: 351-357. 10.1038/ng0495-351.
Article
PubMed
CAS
Google Scholar
Smith SN, Steel DM, Middleton PG, Munkonge FM, Geddes DM, Caplen NJ, Porteous DJ, Dorin JR, Alton EWFW: Bioelectric characteristics of exon 10 insertional cystic fibrosis mouse: comparison with humans. Am J Physiol. 1995, 268 (Cell Physiol 37): C297-C307.
PubMed
CAS
Google Scholar
Rydziel S, Delany AM, Canalis E: AU-rich elements in the collagenase 3 mRNA mediated stabilisation of the transcript by cortisone in osteoblasts. J Biol Chem. 2004, 279: 5397-5404. 10.1074/jbc.M311984200.
Article
PubMed
CAS
Google Scholar
Pasmooij AM, van Zalen S, Nijenhuis AM, Kloosterhuis AJ, Zuiderveen J, Jonkman MF, Pas HH: A very mild form of non-Herlitz junctional epidermolysis bullosa: BP180 rescue by outsplicing of mutated exon 30 coding for the COL 15 domain. Exp Dermatol. 2004, 13: 125-128. 10.1111/j.0906-6705.2004.00141.x.
Article
PubMed
CAS
Google Scholar
McLean WH, Irvine AD, Hamill KJ, Whittock NV, Coleman-Campbell CM, Mellerio JE, Ashton GS, Dopping-Hepenstal PJ, Eady RA, Jamil T, Phillips RJ, Shabbir SG, Haroon TS, Khurshid K, Moore JE, Page B, Darling J, Atherton DJ, Van Steensel MA, Munro CS, Smith FJ, McGrath JA: An unusual N-terminal deletion of the laminin alpha3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndrome. Hum Mol Gen. 2003, 12: 2395-2409. 10.1093/hmg/ddg234.
Article
PubMed
CAS
Google Scholar
Ozisik G, Mantovani G, Achermann JC, Persani L, Spada A, Weiss J, Beck-Peccoz P, Jameson JL: An alternate translation initiation site circumvents an amino-terminal DAX1 nonsense mutation leading to a mild form of X-linked adrenal hypoplasia congenita. J Clin Endocrinol Metab. 2003, 88: 417-423. 10.1210/jc.2002-021034.
Article
PubMed
CAS
Google Scholar
Hwang T-C, Wang F, Yang IC-H, Reenstra WW: Genistein potentiates wild-type and F508del-CFTR channel activity. Am J Physiol. 1997, 273 (Cell Physiol 42): C988-C998.
PubMed
CAS
Google Scholar
Illek B, Zhang L, Lewis NC, Moss RB, Dong J-Y, Fischer H: Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein. Am J Physiol. 1999, 277 (Cell Physiol 46): C833-C839.
PubMed
CAS
Google Scholar
Charizopoulou N, Stanke F, Dorsch M, Hedrich HJ, Tümmler B: High-throughput and cost effective genome wide microsatellite genotyping of two novel cystic fibrosis mutant mouse strains. J Gen Sci Techn. 2004, 3: 30-37.
Google Scholar
Niksic M, Romano M, Buratti E, Pagani F, Baralle FE: Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9. Hum Mol Genet. 1999, 8: 2339-2349. 10.1093/hmg/8.13.2339.
Article
PubMed
CAS
Google Scholar
Buratti E, Baralle FE: Characterisation and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem. 2001, 276: 36337-36343. 10.1074/jbc.M104236200.
Article
PubMed
CAS
Google Scholar
Nissim-Rafinia M, Chiba-Falek O, Sharon G, Boss A, Kerem B: Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations. Hum Mol Genet. 2000, 9: 1771-1778. 10.1093/hmg/9.12.1771.
Article
PubMed
CAS
Google Scholar
Mouchel N, Henstra SA, McCarthy VA, Williams SH, Phylactides M, Harris A: HNF1a is involved in tissue-specific regulation of CFTR gene expression. Biochem J. 2004, 378: 909-918. 10.1042/BJ20031157.
Article
PubMed
CAS
PubMed Central
Google Scholar
Bach G, Moskowitz SM, Tieu PT, Matynia A, Neufeld EF: Molecular analysis of Hurler syndrome in Druze and Muslim Arab patients in Israel: multiple allelic mutations of the IDUA gene in a small geographic area. Am J Hum Genet. 1993, 53: 330-338.
PubMed
CAS
PubMed Central
Google Scholar
Dietz HC, Valle D, Francomano CA, Kendzior RJ, Pyeritz RE, Cutting GR: The skipping of constitutive exons in vivo induced by nonsense mutations. Science. 1993, 259: 680-682.
Article
PubMed
CAS
Google Scholar
Gibson RA, Hajianpour A, Murer-Orlando M, Buchwald M, Mathew CG: A nonsense mutation and exon skipping in the Fanconi anaemia group C gene. Hum Mol Genet. 1993, 2: 797-799.
Article
PubMed
CAS
Google Scholar
Hull J, Shackleton S, Harris A: The stop mutation R553X in the CFTR gene results in exon skipping. Genomics. 1994, 19: 362-364. 10.1006/geno.1994.1070.
Article
PubMed
CAS
Google Scholar
Orci L, Stamnes M, Ravazzola M, Amherdt M, Perrelet A, Sollner TH, Rothman JE: Bidirectional transport by distinct populations of COPI-coated vesicles. Cell. 1997, 90: 335-349. 10.1016/S0092-8674(00)80341-4.
Article
PubMed
CAS
Google Scholar
Zhang H, Peters KW, Sun F, Marino CR, Langs J, Burgoyne RD, Frizzell RA: Cysteine string protein interacts with and modulates the maturation of the cystic fibrosis transmembrane conductance regulator. J Biol Chem. 2002, 277: 28948-28958. 10.1074/jbc.M111706200.
Article
PubMed
CAS
Google Scholar
Yun CH, Oh S, Zizak M, Steplock D, Tsao S, Tse CM, Weinman EJ, Donowitz M: cAMP-mediated inhibition of the epithelial brush border Na+/H+ exchanger, NHE3, requires an associated regulatory protein. Proc Natl Acad Sci USA. 1997, 94: 3010-3015. 10.1073/pnas.94.7.3010.
Article
PubMed
CAS
PubMed Central
Google Scholar
Lamprecht G, Weinman EJ, Yun CH: The role of NHERF and E3KARP in the cAMP-mediated inhibition of NHE3. J Biol Chem. 1998, 273: 29972-29978. 10.1074/jbc.273.45.29972.
Article
PubMed
CAS
Google Scholar
Wang S, Yu H, Derin RB, Guggino WB, Li M: CAP70, a positive regulator for the chloride channel activity of CFTR. Pediatr Pulmonol. 1999, 246-Suppl 19
Cheng J, Moyer BD, Milewski M, Hazama A, Mickle JE, Cutting GR, Stanton BA, Guggino WB: CFTR associates with the PDZ domain protein CAL at the trans-Golgi network. Pediatr Pulmonol. 1999, 168-Suppl 19
Low SH, Chapin SJ, Wimmer C, Whiteheart SW, Komuves LG, Mostov KE, Weimbs T: The SNARE machinery is involved in apical plasma membrane trafficking in MDCK cells. J Cell Biol. 1998, 141: 1503-1513. 10.1083/jcb.141.7.1503.
Article
PubMed
CAS
PubMed Central
Google Scholar
Lambert G, Becker B, Schreiber R, Boucherot A, Reth M, Kunzelmann K: Control of cystic fibrosis transmembrane conductance regulator expression by BAP31. J Biol Chem. 2001, 276: 20340-20345. 10.1074/jbc.M011209200.
Article
PubMed
CAS
Google Scholar
Yoo JS, Moyer BD, Bannykh S, Yoo HM, Riordan JR, Balch WE: Non-conventional trafficking of the cystic fibrosis conductance regulator through the early secretory pathway. J Biol Chem. 2002, 277: 11401-11409. 10.1074/jbc.M110263200.
Article
PubMed
CAS
Google Scholar
Gentzsch M, Chang XB, Cui L, Wu Y, Ozols VV, Choudhury A, Pagano RE, Riordan JR: Endocytic trafficking routes of wild type and deltaF508 cystic fibrosis transmembraneconductance regulator. Mol Biol Cell. 2004, 15: 2684-2696. 10.1091/mbc.E04-03-0176.
Article
PubMed
CAS
PubMed Central
Google Scholar
Vankeerberghen A, Cuppens H, Cassiman JJ: The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions. J Cyst Fibros. 2002, 1: 13-29. 10.1016/S1569-1993(01)00003-0.
Article
PubMed
CAS
Google Scholar
Ko SBH, Zeng W, Dorwart MR, Luo X, Kim KH, Millen L, Goto H, Naruse S, Soyombo A, Thomas PJ, Muallem S: Gating of CFTR by the STAS domain of SLC26 transporters. Nat Cell Biol. 2004, 6: 343-350. 10.1038/ncb1115.
Article
PubMed
CAS
PubMed Central
Google Scholar
Zoo X, Hwang TC: ATP hydrolysis-coupled gating of CFTR chloride channels: structure and function. Biochemistry. 2001, 40: 5579-5586. 10.1021/bi010133c.
Article
Google Scholar
Highsmith WE, Burch LH, Zhou Z, Olsen JC, Boat TE, Spock A, Gorvoy JD, Quittel L, Friedman KJ, Silverman LM: A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med. 1994, 331: 974-980. 10.1056/NEJM199410133311503.
Article
PubMed
CAS
Google Scholar
Highsmith WE, Burch LH, Zhou Z, Olsen JC, Strong TV, Smith T, Friedman KJ, Silverman LM, Boucher RC, Collins FS, Knowles MR: Identification of a splice site mutation (2789+5G-A) associated with small amounts of normal CFTR mRNA and mild cystic fibrosis. Hum Mutat. 1997, 9: 332-338. 10.1002/(SICI)1098-1004(1997)9:4<332::AID-HUMU5>3.0.CO;2-7.
Article
PubMed
CAS
Google Scholar
Chu CS, Trapnell BC, Curristin S, Cutting GR, Crystal RG: Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet. 1993, 3: 151-156. 10.1038/ng0293-151.
Article
PubMed
CAS
Google Scholar
Cuppens H, Lin W, Jaspers M, Costes B, Teng H, Vankeerberghen A, Jorissen M, Droogmans G, Reynaert I, Goossens M, Nilius B, Cassiman JJ: Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest. 1998, 101: 487-496.
Article
PubMed
CAS
PubMed Central
Google Scholar
Groman JD, Hefferon TW, Casals T, Bassas L, Estivill X, Des Georges M, Guittard C, Koudova M, Fallin MD, Nemeth K, Fekete G, Kadasi L, Friedman K, Schwarz M, Bombieri C, Pignatti PF, Kanavakis E, Tzetis M, Schwartz M, Novelli G, D'Apice MR, Sobczynska-Tomaszewska A, Bal J, Stuhrmann M, Macek M, Claustres M, Cutting GR: Variation in a repeat sequence determines whether common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. Am J Hum Genet. 2003, 74: 176-179. 10.1086/381001.
Article
PubMed
PubMed Central
Google Scholar
Rave-Harel N, Kerem E, Nissim M, Madjar I, Goshen R, Augarten A, Rahat A, Hurwitz A, Darvasi A, Kerem B: The molecular basis of partial penetrance of splicing mutations in cystic fibrosis. Am J Hum Genet. 1997, 60: 87-94.
PubMed
CAS
PubMed Central
Google Scholar
Buratti E, Dörk T, Zuccato E, Pagani F, Romano M, Baralle FE: Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 2001, 20: 1774-1784. 10.1093/emboj/20.7.1774.
Article
PubMed
CAS
PubMed Central
Google Scholar
Pagani F, Stuani C, Zuccato E, Kornblihtt AR, Baralle FE: Promoter architecture modulates CFTR exon 9 skipping. J Biol Chem. 2003, 278: 1511-1517. 10.1074/jbc.M209676200.
Article
PubMed
CAS
Google Scholar
Pagani F, Buratti E, Stuani C, Baralle FE: Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9. J Biol Chem. 2003, 278: 26580-26588. 10.1074/jbc.M212813200.
Article
PubMed
CAS
Google Scholar
Cohen FE, Kelly JW: Therapeutic approaches to protein-misfolding diseases. Nature. 2003, 426: 905-909. 10.1038/nature02265.
Article
PubMed
CAS
Google Scholar
Wagner E, Lykke-Andersen J: mRNA surveillance: the perfect persist. J Cell Science. 2002, 115: 3033-3038.
PubMed
CAS
Google Scholar
Gross-Bellard M, Oudet P, Chambon P: Isolation of high molecular weight DNA from mammalian cells. Eur J Biochem. 1973, 36: 32-38. 10.1111/j.1432-1033.1973.tb02881.x.
Article
PubMed
CAS
Google Scholar
Mouse Genome Informatics (MGI). [http://www.informatics.jax.org]
Mekus F, Dörk T, Deufel T, Tümmler B: Analysis of microsatellites by direct blotting electrophoresis and chemiluminescence detection. Electrophoresis. 1995, 16: 1886-1888. 10.1002/elps.11501601309.
Article
PubMed
CAS
Google Scholar
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987, 162: 156-159. 10.1016/0003-2697(87)90021-2.
Article
PubMed
CAS
Google Scholar
Hoof T, Riordan JR, Tümmler B: Quantitation of transcript by the kinetic polymerase chain reaction assay: a tool for monitoring P-glycoprotein gene expression. Anal Biochem. 1991, 196: 161-169. 10.1016/0003-2697(91)90133-E.
Article
PubMed
CAS
Google Scholar
Bremer S, Hoof T, Wilke M, Busche R, Scholte B, Riordan JR, Maass G, Tümmler B: Quantitative expression patterns of multidrug-resistance P-glycoprotein (MDR1) and differentially spliced cystic-fibrosis transmembrane-conductance regulator mRNA transcripts in human epithelia. Eur J Biochem. 1992, 206: 137-149. 10.1111/j.1432-1033.1992.tb16911.x.
Article
PubMed
CAS
Google Scholar
van Dommelen FS, Hamer CM, de Jonge HR: Efficient entrapment of large and small compounds during vesiculation of intestinal microvilli. Biochem J. 1986, 236: 771-778.
Article
PubMed
CAS
PubMed Central
Google Scholar
French PJ, van Doornick JH, Peters RHPC, Verbeek E, Ameen NA, Marino CR, de Jonge HR, Bijman J, Scholte BJ: A F508del mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo. J Clin Invest. 1996, 98: 1304-1312.
Article
PubMed
CAS
PubMed Central
Google Scholar
Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL: The FMR-1 Protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X permutation. Nat Genet. 1993, 4: 335-340. 10.1038/ng0893-335.
Article
PubMed
CAS
Google Scholar
Grubb BR, Vick RN, Boucher RC: Hyperabsorption of Na+ and raised Ca2+-mediated Cl- secretion in nasal epithelia of CF mice. Am J Physiol. 1994, 266 (Cell Physiol 35): C1478-C1483.
PubMed
CAS
Google Scholar